R1 RCM, Health Catalyst Downgraded as KeyBanc Reviews Health-tech Space
Seeking AlphaApr 11 00:56
Keybanc: Lowered the Health Catalyst (HCAT.US) rating from an increase in holdings to a wait-and-see rating.
Zhitong FinanceApr 10 16:50
Health Catalyst Analyst Ratings
BenzingaApr 10 16:41
Health Catalyst Analyst Ratings
BenzingaMar 6 01:35
Buy Rating on Health Catalyst: Strategic Innovation and Client Growth Poised to Drive Performance
TipRanksMar 5 19:06
Barclays Issues a Buy Rating on Health Catalyst (HCAT)
TipRanksMar 5 16:15
KeyBanc Cuts Price Target on Health Catalyst to $10 From $12, Keeps Overweight Rating
MT NewswiresFeb 26 20:48
RBC Capital Remains a Hold on Health Catalyst (HCAT)
TipRanksFeb 26 20:36
Maintaining Buy Rating on Health Catalyst: Strong Sales Pipeline and Margin Outlook Offset Slower Growth Forecast
TipRanksFeb 26 19:35
Canaccord Genuity Maintains Buy on Health Catalyst, Lowers Price Target to $11
BenzingaFeb 23 22:44
Health Catalyst Analyst Ratings
BenzingaFeb 23 22:42
Optimistic Outlook: Health Catalyst's Growth and Profitability Potential Affirm Buy Rating
TipRanksFeb 23 20:49
Stifel Nicolaus Remains a Hold on Health Catalyst (HCAT)
TipRanksFeb 23 20:33
Piper Sandler Sticks to Their Buy Rating for Health Catalyst (HCAT)
TipRanksFeb 23 20:33
Health Catalyst (HCAT) Receives a Buy From Barclays
TipRanksFeb 23 16:05
Analysts Offer Insights on Healthcare Companies: Health Catalyst (HCAT), Regeneron (REGN) and Merck & Company (MRK)
TipRanksFeb 15 16:20
Stifel Nicolaus Sticks to Its Hold Rating for Health Catalyst (HCAT)
TipRanksFeb 7 21:41
Health Catalyst Analyst Ratings
BenzingaJan 26 18:30
Analysts Conflicted on These Healthcare Names: Karuna Therapeutics (KRTX) and Health Catalyst (HCAT)
TipRanksJan 26 17:50
Health Catalyst (HCAT) Gets a Buy From Piper Sandler
TipRanksJan 10 20:18
No Data
No Data